ALGN vs BIOA · P/E 35, rev $2.10B vs rev $9.0M
Align Technology Inc (ALGN) versus BioAge Labs, Inc (BIOA) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. BIOA currently screens at market cap $697.9M.
Not investment advice. Open the ALGN and BIOA stock pages for the full models.
Not investment advice.